Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection

Brazilian Journal of Microbiology

Volumn 45, Issue 2, 2014, Pages 509-514

  Navidinia, Masoumeh ^a   Peerayeh, Shahin Najar ^a   Fallah, Fatemeh ^c   Sajadinia, Raheleh Sadat ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Escherichia coli; hlyD; intI1; Phylogenetic typing groups; Urinary tract infection (UTI)

Indexed keywords

ESCHERICHIA COLI;

ANTIINFECTIVE AGENT; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; HEMOLYSIN; HLYD PROTEIN, E COLI; INTEGRASE; INTEGRON INTEGRASE INTI1;

ANTIBIOTIC RESISTANCE; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; URINARY TRACT INFECTION; URINE;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GENETIC VARIATION; GENOTYPE; HEMOLYSIN PROTEINS; HUMANS; INTEGRASES; MALE; MEMBRANE TRANSPORT PROTEINS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; URINARY TRACT INFECTIONS; URINE;

EID: 84908040661     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822014000200019     Document Type: Article

References (42)

1. Adegoke Anthony A, Okoh Anthony I (2011) Prevalence, antibiotic susceptibility profile and extended spectrum β-lactamase production among Escherichia coli from high vaginal swab (HVS). Afr J Pharm Pharacol 5:1287-1291.
2. Alhaj N., Mariana NS, Raha A, Ishak Z (2007) Prevalence of antibiotic resistance among Escherichia coli from different sources in Malaysia. Res J Pharmacolo 1:44-49.
3. Blango M.G., Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Age Chemother 54:1855-1863.
4. Branger C., Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, Gouriou S., Picard B, Denamur E (2005) Genetic background of Escherichia coli and extended-spectrum betalactamase type. Emerg Infect Dis 11:54-61.
5. Burman W.J., Breese PE, Murray BE, Singh KY, Batal HA, Mackenzie TD, Ogle JW, Wilson ML, Reves RR, Mehler PS (2003) Conventional and molecular epidemiology of trimethoprim- sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 115:358-364.
6. Cantón R., Ruiz-Garbajosa P (2011) Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 11:477-485.
7. Clermont O., Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555-4558.
8. Colgan R., Williams M, Johnson JR (2011) Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician 84:519-526.
9. Dhakal B.K., Kulesus RR, Mulvey MA (2008) Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 38:2-11.
10. Farshad S.H., Japoni A, Hosseini M (2008) Low distribution of integrons among multidrug resistant E.coli strains isolated from children with community -acquired urinary tract infections in Shiraz, Iran. Pol j microbiol 57:193-198.
11. Forbes B.A., Sahm DF, Weissfeld AS (2007) Bailey & Scott's Diagnostic Microbiology, Mosby Press.
12. Foxman B., Manning SD, Tallman P, Bauer R, Zhang L, Koopman JS, Gillespie B, Sobel JD, Marrs KF (2002) Uropathogenic Escherichia coli Are More Likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol 156:1133-1140.
13. Johnson D.E., Lockatell CV, Russell RG, Hebel JR, Island MD, Stapleton A., Stamm WE, Warren JW (1998) Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect Immun 66:3059-3065.
14. Johnson JR (1991) Virulence Factors in Escherichia coli Urinary Tract Infection. Clin Microbiol Rev 4:80-128.
15. Johnson J.R., Delavari P, Kuskowski M, Stell AL (2001) Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 183:78-88.
16. Johnson J.R., Stell A, Delavari P (2001) Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli. Infect Immune 69:1306-14.
17. Johnson J.R., Stell AL, Delavari P, Murray AC, Kuskowski M, Gaastra W (2001) Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J Infect Dis 183:897-906.
18. Johnson J.R., O'Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895-3900.
19. Johnson J.R., Russo TA (2002) Uropathogenic Escherichia coli as agents of diverse non- urinary tract extraintestinal infections. J Infect Dis 186:859-864.
20. Kaper J.B., Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140.
21. Kovalevskaya NP (2002) Mobile Gene Cassettes and Integrons. Mol Biolo 36:196-201.
22. Lim K.T., Yasin R, Yeo CC, Puthucheary S, Thong KL (2009) Characterization of Multidrug Resistant ESBL-Producing Escherichia coli Isolates from Hospitals in Malaysia. J Biomed Biotechno 2009:2009:165637.
23. Manges A.R., Dietrich PS, Riley LW (2004) Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infec Dis 38:329-334.
24. Mokady D., Gophna U, Ron EZ (2005) Extensive gene diversity in septicemic Escherichia coli strains. J Clin Microbiol 43:66-73.
25. Moreno E., Prats G, Sabate M, Perez T, Johnson JR, Andreu A (2006) Quinolone, fluoroquinolone and trimethoprim sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 57:204-211.
26. Moreno E., Andreu A, Perez T, Sabatem M, Johnson JR, Prats G (2006) Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infec 134:1015-1023.
27. Moulin-Schouleur M., Schouler C, Tailliez P, Kao MR, Bree A, Germon P., Oswald E, Mainil J, Blanco M, Blanco J (2006) Common virulence factors and genetic relationships between O18: K1: H7 Escherichia coli isolates of human and avian origin. J Clin Microbiol 44:3484-3492.
28. Muhammad I., Uzma M, Yasmin B, Mehmood Q, Habib B (2011) Prevalence of antimicrobial resistance and integrons in Escherichia Coli from Punjab, Pakistan. Braz J Microbiol 42:462-466.
29. Mulvey M.A., Schilling JD, Martinez JJ, Hultgren SJ (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Nat Acad Sci USA 97:8829-8835.
30. Patti G., Mannini A, Balistreri M, Schito AM (2008) Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 46:480-487.
31. Plos K., Connel H, Jodal U (1995) Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 171:625-631.
32. Rodriguez-Siek K.E., Giddings CW, Doetkott C, Johnson TJ, Fakhr M.K., Nolan LK (2005) Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiol 151:2097-2110.
33. Rodriguez-Siek K.E., Giddings CW, Doetkott C, Johnson TJ, Nolan LK (2005) Characterizing the APEC pathotype. Vet Res 36:241-256.
34. Sabarinath A., Tiwari KP, Deallie C, Belot G, Vanpee G, Matthew V, Sharma R, Hariharan H (2011) Antimicrobial Resistance and Phylogenetic Groups of Commensal Escherichia Coli Isolates from Healthy Pigs in Grenada. Web Med Central 42:1-10.
35. Sabate M., Moreno E, Perez T, Andreu A, Prats G (2006) Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 12:880-886.
36. Schlager T.A., Hendley JO, Bell AL , Whittam TS (2002) Clonal Diversity of Escherichia coli Colonizing Stools and Urinary Tracts of Young Girls. Infect Immun. 70:1225-9.
37. Shigemura K., Arakawa S, Miura T, Nakano Y, Tanaka K, Fujisawa M (2008) Significance of fluoroquinolone resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis 61:226-228.
38. Sivick K.E., Mobley HLT (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78:568-585.
39. Terai A., Ishitoya S, Mitsumori K, OgawaO (2000) Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J Urol 164:1945-1947.
40. Villegas M.V., Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP (2004) Prevalence and characterization of extendedspectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diag Microbiol Infect Dis 49:217-222.
41. Vishalakshi B (2011) Detection of Virulence Markers of Uropathogenic Escherichia coli from Urinary Tract Infection, Karnataka, Banglore, 125 p (Department of Microbiology Mysore Medical College and Research Institute).
42. Walter E., Stamm MD (2001) An epidemic of urinary tract infections. N Eng J Med 345:1055-1057.